（文章来源：证券日报） 证券日报网讯 12月11日，朗玛信息在互动平台回答投资者提问时表示，公司二级市场股价波动受宏观 经济环境、行业政策及市场情绪等多重因素影响。公司会继续深耕"互联网+医疗"主业，全力推进"39AI 医生"在医疗机构的市场推广工作，目前公司处于传统业务调整优化、新业务加速拓展的关键转型过渡 期。未来，公司将进一步聚焦医学人工智能领域的研发创新，持续强化核心竞争力，相关业务进展请关 注公司公告。 ...

证券日报网讯12月11日，朗玛信息（300288）在互动平台回答投资者提问时表示，公司二级市场股价波 动受宏观经济环境、行业政策及市场情绪等多重因素影响。公司会继续深耕"互联网+医疗"主业，全力 推进"39AI医生"在医疗机构的市场推广工作，目前公司处于传统业务调整优化、新业务加速拓展的关键 转型过渡期。未来，公司将进一步聚焦医学人工智能领域的研发创新，持续强化核心竞争力，相关业务 进展请关注公司公告。 ...

中国工程院院士、广州国家实验室主任钟南山，中国医院协会常务副会长毛群安，广东省政务服务和数 据管理局局长王天广，广州市政务服务和数据管理局局长黄津，广州市卫生健康委副主任李铁钢，广州 医科大学副校长付晓东，中国信息产业商会工业互联网分会理事长、广东省数据要素产业协会负责人朱 立锋、金域医学董事长兼首席执行官梁耀铭等出席大会。大会吸引了来自海内外超过400位医疗机构、 IVD企业、药企、大数据及人工智能等领域专家参与，近70名专家学者与企业领军人物登台分享。 王天广表示，健康医疗数据是国家重要基础性战略资源，也是医学人工智能发展的关键基础资源。他发 出三点倡议：一是打造全国领先的高质量数据集，全面赋能诊疗、公卫、新药研发等环节；二是加快建 设医疗数据基础设施，依托可信数据空间链接全流程数据资源，探索医疗健康领域数字经济发展新路 径；三是构建粤港澳大湾区"AI+医疗"创新圈，通过优化数据资产管理、探索数据质量评价标准、推动 数据合规流通，全面支撑人工智能在医疗领域的应用。"我们诚挚期待更多高水平的医疗机构、科研院 所和科技企业，能够参与到大湾区医学人工智能的创新实践中来，与我们携手并进，全力打造全球生物 医药创新 ...

为进一步推动医学人工智能与大数据的融合创新，打造大湾区具有国际影响力的智慧医疗生态，12月7 日，首届大湾区医学人工智能大会暨2025金域医学(603882)大数据与人工智能生态大会在广州隆重召 开。大会由广东省数据要素产业协会、中国生物材料学会体外诊断材料分会、广州医科大学医学检验大 数据与经济研究所主办，广州金域医学检验集团股份有限公司、广州医科大学金域检验学院承办。据 悉，这也是我国第三方医检行业首个人工智能（AI）生态大会，意味着AI在医疗诊断领域的探索和应 用，进入快车道。 中国工程院院士、广州国家实验室主任钟南山，中国医院协会常务副会长毛群安，广东省政务服务和数 据管理局局长王天广，广州市政务服务和数据管理局局长黄津，广州市卫生健康委副主任李铁钢，广州 医科大学副校长付晓东，中国信息产业商会工业互联网分会理事长、广东省数据要素产业协会负责人朱 立锋、金域医学董事长兼首席执行官梁耀铭等出席大会。大会吸引了来自海内外超400位医疗机构、 IVD企业、药企、大数据及人工智能等领域专家参与，近70名专家学者与企业领军人物登台分享。 钟南山院士强调，医学AI绝对不是选择题，而是必答题，不跟上就肯定落后。毛群 ...

Core Insights - The first Greater Bay Area Medical Artificial Intelligence Ecosystem Conference was held in Guangzhou, marking a significant step in the rapid development of AI applications in medical diagnostics in China [1][2] - The conference attracted over 400 experts and featured discussions on the necessity of collaboration among institutions to advance medical AI [2][4] Group 1: Medical AI Development - The development of medical AI is deemed an inevitable choice, with a strong emphasis on the need for collaboration among various institutions, particularly in integrating industry, academia, and research [2][4] - AI is expected to enhance the clinical capabilities of grassroots doctors by leveraging decades of clinical experience, although it cannot replace the human aspects of medical care [2][4] Group 2: Data Space and Collaboration - The "Trusted Medical Data Space" was officially launched by KingMed Medical, which is the only medical institution selected as a pilot for the national trusted data space initiative [3][4] - KingMed Medical has signed cooperation agreements with 18 institutions to foster collaboration in specialized disease model development, AI applications, and data flow [4][5] Group 3: KingMed Medical's Innovations - KingMed Medical has developed a comprehensive product blueprint that includes intelligent product services, specialized disease model services, user health services, and the trusted medical data space [4] - Since implementing the "Medical Testing 4.0" strategy in 2020, KingMed has created the industry's first large model "Yujian Yiyan" and the intelligent agent "Xiaoyue Yi," interpreting nearly 8 million reports [4]

Core Insights - The "Hang Xiaoyu" initiative, developed by the Hangzhou Municipal Health Commission, has been recognized as one of the eight exemplary cases in medical artificial intelligence innovation and practice at a national conference [1][2] - This initiative focuses on addressing family childcare needs and children's health management through an intelligent system that provides various smart parenting services [1] Group 1: Smart Parenting Services - "Hang Xiaoyu" offers over 50 services, including "support for childbirth," "peaceful pregnancy," "comfortable parenting," and "reliable childcare," allowing parents to interact with the system for immediate assistance [1] - The system can recommend nearby childcare institutions and facilitate online appointments for visits, health checks, and enrollment [1] Group 2: Child Development Risk Assessment - Parents can conduct home assessments of their children's development using a multi-modal model that analyzes uploaded videos of children's behaviors in areas such as motor skills, language, cognition, and social interaction [2] - The generated development risk assessment reports are sent to community pediatricians, creating a closed-loop management system for screening, diagnosis, and intervention [2] Group 3: System Usage and Impact - As of now, "Hang Xiaoyu" has accumulated over 86,000 authoritative knowledge entries, with more than 3 million visits and services provided to nearly 720,000 parents [2] - Since the launch of the home self-assessment application in March, over 300,000 parents have utilized the tool for self-assessment [2]

Core Points - Yidu Tech (02158) shares rose over 6%, currently up 6.27% at HKD 7.12, with a trading volume of HKD 112 million [1] - The company announced that its affiliate, Tianjin Happy Life Technology Co., Ltd., won a bid for the Phase III clinical research project of human nerve growth factor (SMR001) eye drops from Shandong Yandu Biotechnology Co., Ltd., with a total project value of approximately RMB 55.82 million [1] - At the "First Medical Artificial Intelligence Conference and Health Industry AI Application and Development Exhibition" held in Jinan, Dr. Li Linfeng, Vice President of Technology Innovation and AI Architect at Yidu Tech, introduced the "Doctor Copilot" built on the foundation of "big data + Yidu domain-specific large model," which has been implemented in several hospitals to enhance diagnostic efficiency and quality, aiding in the intelligent and standardized upgrade of clinical practices [1] Summary by Categories Financial Performance - Yidu Tech's stock price increased by 6.27%, reaching HKD 7.12, with a trading volume of HKD 112 million [1] Project Development - The company secured a project worth approximately RMB 55.82 million for the Phase III clinical research of SMR001 eye drops [1] Technological Innovation - The "Doctor Copilot" technology, which integrates clinical workflows, has been successfully implemented in multiple hospitals, improving diagnostic efficiency and quality [1]

消息面上，医渡科技公布，近期，公司联属公司天津开心生活科技有限公司中标山东衍渡生物科技有限 公司重组人神经生长因子(SMR001)滴眼液Ⅲ期临床研究项目，项目总金额约为人民币5582万元。此 外，由《中国卫生信息管理杂志》社主办的"首届医学人工智能大会暨卫生健康行业AI应用与产业发展 展览会"近日于济南举办。在大会"AI驱动医疗质量提升"论坛上，医渡科技技术创新副总裁、AI架构师 李林峰博士介绍，医渡科技以"大数据+医渡垂域大模型"为技术底座，构建了深度融合临床工作流的"医 生Copilot"。目前，医生Copilot已在多家医院落地应用，有效提升诊疗效率与质量，助力临床实现智能 化、规范化升级。 智通财经APP获悉，医渡科技(02158)涨超6%，截至发稿，涨6.27%，报7.12港元，成交额1.12亿港元。 ...

Core Insights - The first National Medical Artificial Intelligence Conference was held in Jinan, showcasing the innovative practices of digital transformation in healthcare, with Tai'an Central Hospital presenting its "Smart Hospital Operation Command Center System" [1][4] - The system was recognized as a typical case of medical artificial intelligence innovation and practice, attracting significant attention from experts and peers in the medical field [1][4] Group 1: System Features and Benefits - The "Smart Hospital Operation Command Center" integrates core business data from outpatient, inpatient, and logistics operations, enabling real-time monitoring and visualization of hospital operational status [2] - The system captures key metrics such as patient flow, medical resource utilization efficiency, and equipment operation status, providing data-driven decision support to enhance healthcare service quality and management efficiency [2] Group 2: Industry Recognition and Expert Engagement - During the exhibition, leaders and experts from the Shandong Provincial Health Big Data Center and the Shandong Provincial Health Commission engaged with Tai'an Central Hospital, discussing the system's functionality, application outcomes, and future plans [3] Group 3: Commitment to Innovation and Future Plans - As a representative of municipal hospitals in Shandong Province, Tai'an Central Hospital actively explores smart hospital construction, showcasing its achievements in the field of medical artificial intelligence [4] - The hospital aims to continuously improve system functionality and extend the benefits of smart solutions to more patients and healthcare professionals [4]

Core Insights - The Fourth Global Digital Trade Expo's Digital Healthcare Industry Matching Conference was held on September 25 in Hangzhou, highlighting advancements in medical AI [1] - The establishment of a joint laboratory for medical AI evaluation and verification aims to create a "gold standard" for the compliant, safe, and efficient application of AI in healthcare [1] - A global recruitment plan for innovative entrepreneurial teams in the medical AI sector has been launched, providing R&D space, funding, and policy support to attract high-quality AI medical projects [1] Group 1 - The joint laboratory is a collaboration between the Zhejiang Provincial National AI Application Pilot Base, the Chinese Academy of Medical Sciences, and the China Academy of Information and Communications Technology [1] - The initiative aims to facilitate the entire development chain of medical AI from concept validation to industrial implementation [1] - The recruitment plan is designed to attract global talent and projects to enhance the medical AI landscape in Zhejiang [1]